Wang J - In the present study, the researcher tested the effectiveness and safety of oral immunotherapy (OIT) and epicutaneous immunotherapy (EPIT) to induce desensitization to peanut and identified factors that should be considered when guiding families in treatment decisions. According to findings, OIT and EPIT will provide additional options for patients and families to manage peanut allergies. Recent data from phase III studies on OIT and EPIT as well as real-world data on OIT advance the understanding of the efficacy and safety of these approaches. Recent data from Phase III OIT and EPIT studies as well as real-world OIT data advance the understanding of these strategies' effectiveness and protection. Continuous studies are aimed at discovering biomarkers to strengthen standards for patient selection as well as developing new therapeutic strategies.